Cambridge, UK — BioSilta Ltd, a developer of advanced, reagent-based microbial growth systems, today announced the signing of a non-exclusive worldwide distribution agreement with Sigma-Aldrich®(Nasdaq: SIAL). Research scientists now have the option of ordering BioSilta’s EnPresso® growth systems for microbial cell cultures through global supplier Sigma-Aldrich. BioSilta’s lead product range, EnPresso B growth systems, offer […]
Wellington, New Zealand — Magritek, world leading providers of benchtop NMR and MRI instruments, announced that New Zealand institutional investor, Rangatira Limited, has increased its stake in the company Last year Rangatira, the Wellington-based investment company, acquired a 12% stake in Magritek for an undisclosed sum. As part of that transaction, Rangatira entered into a […]
Ann Arbor, MI –– Rubicon Genomics, Inc., today announced that it has signed agreements with new distributors in Europe, North Africa and Asia to further expand the availability of its DNA library preparation products for arrays and Illumina® next-generation sequencing (NGS) platforms, including ThruPLEX® DNA-seq, PicoPLEXTM DNA-seq, and PicoPLEX WGA Kits. Separately, Rubicon announced that […]
Redwood City, Calif. -– QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced today that its business area, QIAGEN Bioinformatics, has been named by Genomics England (GeL) an assessment winner for the UK100K project, along with other life science technology providers. The company will be providing project researchers access to Ingenuity® Variant Analysis™, a powerful […]
SomaLogic, Inc., announced today that the National Institutes of Health (NIH) Center for Human Immunology, Autoimmunity and Inflammation (CHI) will use the SOMAscan™ proteomics assay for research with collaborators across the NIH. It is expected that the SOMAscan assay will be installed and fully functional at CHI by the beginning of 2015, under the leadership […]
FRANKLIN LAKES, N.J.– BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has acquired GenCell Biosystems, a privately-held Irish biotech company that has developed proprietary technologies that address key biological analysis protocols – from library preparation of Next Generation Sequencing (NGS) to genotyping for agricultural applications. “We […]
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today it made a technology acquisition from AbVitro Inc, a company focused on therapeutic target discovery. Roche obtained exclusive rights to a primer extension based target enrichment technology and associated patent applications filed by AbVitro. Under the terms of the agreement, AbVitro and Roche scientists will collaborate on […]
Berlin, Germany, Belfast, Northern Ireland, and Boulder, CO, USA — Marine toxins can have serious implications for both public health and the economy. As a result, routine monitoring for a number of recognized marine toxins in edible shellfish is a regulatory requirement in many areas worldwide. Animal-based assays have historically been used to indicate sample […]
Porvair Sciences, a world leader in applications optimised microplates and microplate equipment has appointed SPEware Corporation (Baldwin Park, CA) as its exclusive partner for supporting and servicing its UltraVap, MiniVap and UltraVap Mistral microplate sample concentration systems. Steve Knight, Sales & Marketing Director at Porvair Sciences commented “We have seen US demand for affordable 96-well […]
ZURICH & DEVENS, Mass.– ChromaCon AG entered into a licensing agreement with LEWA Process Technologies. This agreement will enable the further development of each company’s current and future biopharmaceutical manufacturing technologies. “Clients are now able to employ the GMP manufacturing technologies and global commercial reach of LEWA to further advance the use of ChromaCon’s CaptureSMB […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
